Core Points - The company is currently involved in a lawsuit as the plaintiff, seeking payment of 17,892,267.12 yuan plus interest from the defendant for unpaid goods [1][2] - The case is at the first-instance judgment stage, and the company is unable to determine the impact on current or future profits until the appeal period is over [1][2] - The court found insufficient evidence to support the company's claims, leading to a judgment against the company [2] Summary by Sections Lawsuit Details - The company filed a civil lawsuit against an agricultural company for the recovery of unpaid goods amounting to 17,892,267.12 yuan, along with interest calculated at 1.5 times the one-year Loan Prime Rate (LPR) from the date of the lawsuit [1][2] - The lawsuit includes claims for litigation costs to be borne by the defendant [1] Court Ruling - The court applied a simplified procedure for the hearing and found that the evidence presented by the company was insufficient to support its claims [2] - The company has the right to appeal the judgment within fifteen days of receiving the court's decision [2] Impact on Financials - The company is currently unable to assess the impact of the lawsuit on its profits for the current or future periods due to the ongoing appeal process [1][2] - As of the announcement date, the company has no other undisclosed significant litigation or arbitration matters [2]

证券代码：600227 证券简称：赤 天 化 编号：2025-037 贵州赤天化股份有限公司 关于公司提起诉讼的进展公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重 大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 是否会对上市公司损益产生负面影响：目前案件所处阶段为一 审判决，尚处于上诉期内，暂无法准确判断对公司本期利润或期后利 润的影响，公司将及时对该诉讼事项的进展情况履行相关信息披露义 务，敬请广大投资者注意投资风险。 2025 年 5 月 19 日，贵州赤天化股份有限公司（以下简称"公司" 或"原告"）收到贵州省贵阳市云岩区人民法院（以下简称"云岩区 人民法院"）《民事判决书》（2025）黔 0103 民初 3320 号，现将有关 情况公告如下： 1、驳回原告贵州赤天化股份有限公司的诉讼请求。 2、案件受理费减半收取 64577 元，由原告贵州赤天化股份有限 公司负担。 如不服本判决，可在判决书送达之日起十五日内向本院递交上诉 状，并按对方当事人人数提出副本，上诉于贵州省贵阳市中级人民法 院。 三、本次诉讼对公司本期利润或期后利润等的影响 一、本次 ...

北京植德律师事务所 关于贵州赤天化股份有限公司 2024 年年度股东大会的 法律意见书 植德京（会）字[2025]0056号 二〇二五年五月 北京市东城区东直门南大街 1 号来福士中心办公楼 12 层 邮编：100007 12th Floor, Raffles City Beijing Offices Tower, No.1 Dongzhimen South Street,Dongcheng District, Beijing 100007 P.R.C. 电话（Tel）: 010-56500900 传真（Fax）: 010-56500999 www.meritsandtree.com 北京植德律师事务所 关于贵州赤天化股份有限公司 2024 年年度股东大会的 法律意见书 植德京（会）字[2025]0056 号 致：贵州赤天化股份有限公司（贵公司） 北京植德律师事务所（以下简称"本所"）接受贵公司的委托，指派律师出席 并见证贵公司 2024 年年度股东大会（以下简称"本次会议"）。 本所律师参加本次会议进行见证，并根据《中华人民共和国公司法》（以下简称 "《公司法》"）、《中华人民共和国证券法》（以下简称"《证 ...

证券代码：600227 证券简称：赤天化 公告编号：2025-036 贵州赤天化股份有限公司 2024年年度股东大会决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 本次会议是否有否决议案：无 1、公司在任董事9人，出席9人，其中独立董事范其勇以视频方式出席会议； 2、公司在任监事3人，出席3人； 3、董事会秘书先正红出席会议；其他高级管理人员列席会议。 二、 议案审议情况 (一) 非累积投票议案 一、 会议召开和出席情况 | 1、出席会议的股东和代理人人数 | 364 | | --- | --- | | 2、出席会议的股东所持有表决权的股份总数（股） | 654,866,410 | | 3、出席会议的股东所持有表决权股份数占公司有表决权股 | | | 份总数的比例（%） | 38.9559 | (四) 表决方式是否符合《公司法》及《公司章程》的规定，大会主持情况等。 会议由公司董事会召集，董事长丁林洪主持，采取现场投票及网络投票相结 (一) 股东大会召开的时间：2025 年 5 月 19 日 (二) ...

Overview - The company announced a supplementary notice regarding the payment of guarantee fees to related parties and the associated transactions [1] Transaction Details - The board of directors approved a proposal for the company to pay guarantee fees to related parties, which will be submitted for review at the 2024 annual general meeting [1] - The company’s wholly-owned subsidiary, Guizhou Daqin Tumor Hospital Co., Ltd., will receive a fixed asset loan from the Agricultural Development Bank of China, with guarantees provided by Guizhou Chitianhua Group and Zunyi Tiantong Plastic Co., Ltd. [1] - The guarantee fee payment is based on the assessed value of the collateral provided for the loan [2] Asset Evaluation - The assessed value of the collateral, which includes 66 properties and commercial spaces, is determined to be 200.8363 million yuan, reflecting a decrease of 22.23% from the previous bank assessment [2] - The decline in assessed value is attributed to reduced usable life of the assets and a sluggish real estate market [2] Adjusted Guarantee Fee Structure - The pricing basis for the guarantee fee will be adjusted according to the new assessed value [3] - The maximum estimated total guarantee fee is now capped at 34.6443 million yuan, calculated based on the new assessed value over a maximum period of 11.5 years [5] Future Implications - The adjustment in the assessed value of the collateral will lead to a reduction in the guarantee fees payable by the company [5] - The company aims to negotiate with the Agricultural Development Bank to release the guarantees by 2028, contingent on the hospital's operational performance [5]

Core Viewpoint - The evaluation of fixed assets, specifically buildings and structures owned by Guizhou Chitianhua Group Co., Ltd., is set for April 30, 2025, with detailed assessments provided for various properties [1][2][3][4][5][6]. Group 1: Asset Evaluation Details - The evaluation includes multiple properties such as factories, offices, and other facilities located in the Chishui City Chemical Road area, with ownership attributed to Guizhou Chitianhua Group Co., Ltd. [1][2][3]. - The assessment lists the original value, net value, and estimated value of each property, along with their respective construction dates and structural types [1][2][3][4]. - The total assessed value of the properties is approximately 133,062,800.00 RMB, with a detailed breakdown of individual properties and their respective values [6]. Group 2: Property Characteristics - Properties include various types of buildings such as factories, offices, and service facilities, with specific details on their construction area and rights [1][2][3][4]. - The evaluation also notes the age and condition of the buildings, indicating the depreciation and appreciation rates for each asset [1][2][3]. - The properties are primarily located in the Chishui City area, with specific land use rights documented for each asset [1][2][3][4].

Core Viewpoint - Guizhou Chitianhua Co., Ltd. reported a challenging financial year for 2024, with a net loss attributed to various operational factors, despite some growth in revenue from its chemical and medical service segments [1][2][3]. Financial Performance - The company achieved operating revenue of CNY 238,006.12 million in 2024, with a net loss attributable to shareholders of CNY -8,669.35 million [1][19]. - The chemical segment generated revenue of CNY 226,020.86 million, contributing a net profit of CNY 13,086.61 million, while the medical services segment reported a revenue of CNY 10,430.55 million with a net loss of CNY -12,867.21 million [1][3]. - The coal segment saw an increase in production and sales, with a slight rise in prices compared to the previous year [1]. Asset and Liability Overview - As of December 31, 2024, total assets amounted to CNY 483,556.81 million, reflecting a 2.58% increase from the beginning of the year [2][20]. - The company's debt ratio rose to 47.37%, an increase of 3.57% from the previous year [2]. Production and Sales Data - The company sold 66.11 million tons of urea, a year-on-year increase of 6.36%, and 32.81 million tons of methanol, up 46.16% [2][29]. - The production of synthetic ammonia, methanol, and urea increased by 7.06%, 42.36%, and 7.98% respectively compared to the previous year [3][29]. Future Outlook - For 2025, the company plans to produce 55.80 million tons of urea and 30 million tons of methanol, with a projected total revenue of CNY 217,830.13 million and a net loss of CNY -7,118.09 million [9][33]. - The company anticipates challenges due to market fluctuations in commodity prices, particularly for urea and methanol, which are influenced by international and domestic conditions [34].

本资产评估报告依据中国资产评估准则编制 贵州赤天化股份有限公司拟审议 支付担保费用所涉及的其指定 房地产的市场价值 餐产评估报告 中天华资评报字[2025]黔第1031号 (共一册,第一册) 北京中う 限责任公司 -- the state of the same of the with the state 中国资产评估协会 资产评估业务报告备案回执 | 报告编码: | 5211020122521301202500030 | | --- | --- | | 合同编号: | 中天华合同字[2025]黔P033号 | | 报告类型: | 非法定评估业务资产评估报告 | | 报告文号: | 中天华资评报字[2025]黔第1031号 | | 报告名称: | 贵州赤天化股份有限公司拟审议支付担保费用所涉及的其指定房 地产的市场价值资产评估报告 | | 评估结论: | 200,836,300.00元 | | 评估报告日: | 2025年05月08日 | | 评估机构名称: | 北京中天华资产评估有限责任公司 | | 签名人员: | 邓泽华 (资产评估师) 正式会员 编号:52000209 | | | 余颖莉 (资产评估师) ...

证券代码：600227 证券简称：赤 天 化 公告编号：2025-035 贵州赤天化股份有限公司 关于向关联方支付担保费暨关联交易的补充公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大 遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 一、情况概述 2025 年 4 月 28 日，贵州赤天化股份有限公司（以下简称：公司）召开了第 九届十五次董事会会议，审议通过了《关于向关联方支付担保费暨关联交易的议 案》，并提交公司 2024 年年度股东大会审议。贵州赤天化集团有限责任公司（以 下简称：赤天化集团）及贵州赤天化集团遵义天通塑料有限责任公司（以下简称： 天通公司）为公司全资子公司贵州大秦肿瘤医院有限公司（以下简称：大秦医院） 向中国农业发展银行清镇市支行（以下简称：农业发展银行）固定资产贷款提供 抵押担保，大秦医院拟向关联方支付担保费（以下简称：本次交易）。具体内容 详见公司 2025 年 4 月 29 日在《中国证券报》《上海证券报》和《证券时报》以 及上海证券交易所网站(www.sse.com.cn)上披露的《贵州赤天化股份有限公司关 于向关联方支付担保费暨关联交易公告 ...

贵州赤天化股份有限公司 GUIZHOU CHITIANHUA CO.,LTD. 2024 年年度股东大会 会议资料 二〇二五年五月 贵州赤天化股份有限公司 2024 年年度股东大会会议资料 贵州赤天化股份有限公司 2024 年年度股东大会现场会议议程 会议时间：2025 年 5 月 19 日下午 14:00 会议地点：贵州省贵阳市阳关大道 28 号赤天化大厦 22 楼会议室 主 持 人：董事长丁林洪 | 序号 | 会 议 议 程 | 资料 页码 | | --- | --- | --- | | 1 | 宣布大会开幕 | - | | 2 | 宣布到会股东人数及代表股份数 | - | | 3 | 审议《2024 年度董事会工作报告》 | 1 | | 4 | 审议《2024 年度监事会工作报告》 | 6 | | 5 | 年年度报告》及报告摘要 审议《2024 | 10 | | 6 | 审议《2024 年度财务决算方案》 | 11 | | 7 | 年度利润分配及资本公积金转增股本方案》 审议《2024 | 19 | | 8 | 审议《2025 年度财务预算方案》 | 20 | | 9 | 审议《关于公司为子公司、孙公司 ...